Covovax
- India
Current COVID strain mild, SII producing 5-6million Covovax doses: Adar Poonawalla
Pune: The prevalent strain of COVID-19 is mild and the Serum Institute of India (SII) has already produced five to six million doses of the Covovax vaccine, said the company’s chief executive officer…
- India
Serum Institute of India restarts manufacturing of Covishield
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said…
- India
Govt panel recommends Covovax inclusion in vax drive for 12 and above
New Delhi: Covid vaccine Covovax’s inclusion in the vaccination programme for the 12-17 years age group has been recommended by the Covid-19 Working Group, official sources said on Sunday. The Central Drugs…